Document is current

Article History

Received: 9 August 2024

Accepted: 11 October 2024

First Online: 6 November 2024

Declarations

:

: This research was reviewed and approved by the Hackensack Meridian Institutional Review Board (Pro2023-0267).

: Not applicable.

: EAH reports grants from NIH/National Cancer Institute and the Bristol MyersSquibb Foundation during the conduct of the study. JF reports institutional research support from Amgen, Bristol Myers Squibb Foundation, Disability Inclusion Network for Tobacco Control and Cancer Prevention, Patient Centered Oriented Research Institute, Thermo Fisher Scientific (all active). Institutional honoraria for serving on Patient Advocacy Advisory Boards for Bristol Myers Squibb, Merck, and Takeda. Personal honoraria for serving on Data Safety Management Board for research funded by the Patient Centered Oriented Research Institute. AC reports institutional research support for consulting fees from Daiichi Sankyo, Novartis, Seagen, and Genentech, and institutional honarium for advisory board participation from Glaxo Smith Kline. LC-B reports grants from the NIH/National Cancer Institute, Department of Defense, Gilead Sciences, and Merck Foundation during the conduct of the study.